Methotrexate-Associated Lymphoproliferative Disorder in a Patient with Psoriasis: A Case Report and Review of the Literature

<div>18F-FDG PET/CT performed four months after MTX discontinuation, showing a reduction of the hypermetabolic activity of spleen and lymph nodes, and a spontaneous resolution of the hypermetabolic involvement of lungs and bone marrow.</div>

Case Reports in Hematology

fig2

Figure 2

Figure 2: Methotrexate-Associated Lymphoproliferative Disorder in a Patient with Psoriasis: A Case Report and Review of the Literature 